Literature DB >> 30520764

Reasons why the diagnosis of serrated polyposis syndrome is missed.

Yasmijn J van Herwaarden1, Simon Pape1, Elisa Vink-Börger2, Polat Dura1, Fokko M Nagengast1, Ludger S M Epping3, Tanya M Bisseling1, Iris D Nagtegaal2.   

Abstract

OBJECTIVES: Serrated polyposis syndrome (SPS) is a relatively new and under-recognized colorectal cancer (CRC) predisposition syndrome. Previous studies have reported miss-rates of SPS diagnosis varying from 40 to 82%. As SPS patients and their first-degree relatives have an increased risk of CRC, early recognition is important. We aimed to determine the miss-rate of SPS and to determine the reasons for missed diagnosis. PATIENTS AND METHODS: We retrospectively identified all patients diagnosed with at least one colorectal polyp or carcinoma detected at our tertiary referral center between January 1986 and July 2013 using the nationwide pathology registry. On the basis of cumulative polyp count with size and location, SPS patients were identified. We checked whether the SPS diagnosis was made in the medical files and, if not, what might have been the reason for missing the diagnosis.
RESULTS: We randomly assessed 5000 patients, of whom 25 patients fulfilled the WHO criteria for SPS. In six patients, no previous SPS diagnosis had been made, leading to a miss-rate of 24.0% (95% confidence interval: 7.3-40.7). The reasons for missed diagnosis were polyps removed before establishment of the WHO criteria, unavailable pathology reports, and failure to apply the criteria by the clinician.
CONCLUSION: The miss-rate for the diagnosis of SPS is considerable, even during longer follow-up with repeated colonoscopies. A preventable reason for missing SPS cases is failure to apply the WHO criteria. Awareness of this CRC predisposition syndrome needs to be raised to decrease the miss-rate of SPS.

Entities:  

Mesh:

Year:  2019        PMID: 30520764     DOI: 10.1097/MEG.0000000000001328

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

Review 1.  Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.

Authors:  Yasmijn J van Herwaarden; Lieke M Koggel; Femke Simmer; Elisa M Vink-Börger; Polat Dura; Gerrit A Meijer; Fokko M Nagengast; Nicoline Hoogerbrugge; Tanya M Bisseling; Iris D Nagtegaal
Journal:  Histopathology       Date:  2020-12-25       Impact factor: 5.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.